CORE 1: Administrative

该计划项目管理核心旨在通过多个PI提供科学领导 领导、指导委员会和内部和外部咨询委员会。频繁的会议， 电话会议和亲自确保该计划的顺利运行和协作性质。的 Program Project于2012年首次构想，自那时以来，该团队一直在共同努力， 计划项目取得成果。 领导层由多重PI机制管理。流行病学家玛丽安贝里克博士 在黑色素瘤预防和生存领域工作了近30年的是联系PI和南希博士 托马斯是一位皮肤病学家和分子流行病学家，他和托马斯一起工作了15年多， 正在进行的大型黑色素瘤项目。指导委员会由项目负责人、 核心领导人和几个主要参与者：玛丽安贝里克-项目一，南希托马斯-项目二， 伊娃Hernando-Monge -项目三，沈荣来-项目四，科林贝格-项目四， 生物信息学核心，Klaus Busam -生物标本核心，Irene Orlow -生物标本核心，Ivan Gorlov - 生物信息学核心，克里斯托弗阿莫斯-项目一和生物信息学核心，马克恩斯特夫-项目一。 指导委员会成员每周举行电话会议，并将继续 在可预见的未来每隔一周见一次面他们每年至少亲自会面一次， 一年中有好几次。内部顾问委员会由两名黑色素瘤肿瘤学家组成， 研究-保罗查普曼和Stergios Moschos，生物统计学家- Venkat Seshan，实验室科学家， 是甲基化研究的专家--史蒂夫·贝林斯基和皮肤病理学家--马库斯·博森伯格。我们将 在获得资助后任命一个外部咨询委员会。该小组将由一名分子肿瘤学家、一名遗传学家、 免疫学家和表观遗传学专家 行政核心将负责财政管理和赠款报告。还将 负责管理、协调和分发机构提供的临床数据。 此外，它还负责项目之间以及与国家 癌症研究所.它还负责遵守所有机构，政府和NCI法规 和政策

This Program Project Administrative Core was designed to provide scientific leadership through the Multiple PI leadership, the Steering Committee and the Advisory Board, Internal and External. Frequent meeting by teleconference and in-person assures the smooth running and collaborative nature of the Program. The Program Project was first envisioned in 2012 and the team has been working together since then to bring the Program Project to fruition. The Leadership is managed by a Multiple PI mechanism. Dr. Marianne Berwick, an epidemiologist who has worked in the area of melanoma prevention and survival for almost 30 years is the contact PI and Dr. Nancy Thomas, a dermatologist and molecular epidemiologist, have both worked together for more than 15 years on large melanoma projects that are ongoing. The Steering Committee is made up of the Project Leaders, the Core Leaders and several key participants: Marianne Berwick – Project One, Nancy Thomas – Project Two, Eva Hernando-Monge – Project Three, Ronglai Shen – Project Four, Colin Begg – Project Four and Bioinformatics Core, Klaus Busam – Biospecimen Core, Irene Orlow – Biospecimen Core, Ivan Gorlov – Bioinformatics Core, Christopher Amos – Project One and Bioinformatics Core, Marc Ernstoff – Project One. The members of the Steering Committee have been meeting by teleconference weekly and will continue to meet every other week for the foreseeable future. They have met in person at least annually and sometimes several times in the year. The Internal Advisory Board consists of two melanoma oncologists with laboratory research – Paul Chapman and Stergios Moschos, a Biostatistician – Venkat Seshan, a laboratory scientist who is an expert in methylation studies – Steve Belinsky, and a dermatopathologist – Marcus Bosenberg. We will name an external advisory board when funded. This will be composed of a Molecular Oncologist, a geneticist, an immunologist and an epigenetics expert. The Administrative Core will be responsible for Fiscal management and grant reporting. It will also be responsible for management, harmonization and distribution of the clinical data provided by the institutions. Furthermore, it is responsible for the harmonious communication among the projects and with the National Cancer Institute. It is also responsible for compliance with all institutional, governmental and NCI regulations and policies.